Skip to main content
BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
8.05
-0.09 (-1.11%)
At close: Jan 8, 2025, 4:00 PM
8.09
+0.04 (0.50%)
After-hours: Jan 8, 2025, 5:50 PM EST

BioCryst Pharmaceuticals Revenue by Segment
Period Ending Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
Orladeyo
404.36M 373.72M 346.44M 325.99M 305.84M 286.13M 270.34M 251.63M
Orladeyo Growth
32.21% 30.61% 28.15% 29.55% - - - -
Other
8.22M 8.51M 8.95M 5.42M 11.72M 20.51M 19.34M 19.19M
Other Growth
-29.82% -58.49% -53.71% -71.75% - - - -

Revenue by Type
Period Ending Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
Product
404.06M 373.29M 345.80M 324.70M 312.02M 301.95M 286.33M 267.71M
Product Growth
29.50% 23.63% 20.77% 21.29% - - - -
Collaborative and Other
8.52M 8.95M 9.59M 6.72M 5.54M 4.70M 3.35M 3.12M
Collaborative and Other Growth
53.86% 90.65% 186.19% 115.46% - - - -

Revenue by Geography
Period Ending Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
Orladeyo
358.41M 330.57M 307.48M 288.36M 272.55M 257.39M 243.27M 226.36M
Orladeyo Growth
31.50% 28.43% 26.39% 27.39% - - - -
Other
45.94M 43.15M 38.97M 37.63M 33.29M 28.74M 27.07M 25.28M
Other Growth
38.00% 50.14% 43.94% 48.88% - - - -
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.